Vikas Dandekar
Why are Indian oncologists turning to Chinese cancer medicines?
Lower-cost, latest-generation immunotherapies from China are a shot in the arm for Indian cancer patients who have been priced out of treatment by expensive drugs from western MNCs
- Vikas DandekarRica Bhattacharyya
- THE ECONOMIC TIMES
How a blockbuster GLP-1 drug was almost Made in India
Zydus saw success with an oral GLP-1 drug in 2010, but shelved the drug's clinical development due to costs
- Vikas Dandekar
- THE ECONOMIC TIMES